FeesSafety
Pluang+

OneMedNet Q3 revenue jumps 250%, reiterates $12-14M Q4 outlook

Company Fundamentals
17 Nov 2026, 16:15 WIB
GlobeNewsWire
View Source
Bullish
OneMedNet Q3 revenue jumps 250%, reiterates $12-14M Q4 outlook

OneMedNet reported a 250% revenue increase in Q3 2026 to $1.02 million, driven by scaled delivery of AI-driven healthcare data. The company reiterated its Q4 revenue guidance of $12-14 million, expecting faster revenue growth as customer data acceptance progresses. This growth reflects OneMedNet's expanding sales funnel and its ability to convert contracts into delivered data at scale, positioning it strongly for year-end performance.

OneMedNet's Q3 2026 financial results provide context for readers interested in healthcare data companies. As of Nov 17, 2026 21:01 WIB, among 150 priced Health-sector US stocks tradable on Pluang, 40 rose and 103 fell. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 8.68 with a 1-day change of +2.12%, GH (Guardant Health Inc. Common Stock) at USD 146.98 with +2.05%, and NVO (Novo Nordisk A/S) at USD 40.81 with -1.90%, where Pluang order activity was 94% Sell and 6% Buy.

More News

Global metal pipe market to reach $190B by 2035, driven by construction and oil & gas demand.

Global metal pipe market to reach $190B by 2035, driven by construction and oil & gas demand.

The global metal pipe market is projected to grow at a 4.4% CAGR, reaching $190.4 billion by 2035. Growth is fueled by rising demand in construction, real estate, oil & gas, and infrastructure modernization. Technological advances, sustainability eff...

Market News
Bullish
50 minutes ago
Global biotech market hits $2.02T in 2026, set to triple by 2035 amid record deals and strong Q3 growth.

Global biotech market hits $2.02T in 2026, set to triple by 2035 amid record deals and strong Q3 growth.

The global biotechnology market reached a valuation of USD 2.02 trillion in 2026 and is projected to grow to USD 6.34 trillion by 2035, driven by a 13.61% CAGR. Leading companies like Amgen, Gilead, Regeneron, Vertex, and Moderna reported strong thir...

Bullish
50 minutes ago
Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...

Others
Bullish
2 hours ago
RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand Company Ltd. has released its first mobile game, Palazzo Chronicles: Match 3, on the Google Play Store. The free-to-play match-3 puzzle game features over 270 levels where players restore a royal palace set in Risorgimento Italy. This launch...

Others
Bullish
2 hours ago
Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank announced three key leadership appointments to strengthen its Commercial Banking division. Edward Galan will lead Middle Market Lending, Dawn Scocco will manage portfolio and credit risk, and John Maio will head Treasury Management Ser...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App